Virtus LifeSci Biotech Clinical Trials ETF (BBC) Holdings $19.55 +0.47 (+2.46%) Closing price 05/2/2025 04:10 PM EasternExtended Trading$19.57 +0.02 (+0.10%) As of 05/2/2025 05:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsRatingsBuy This Stock Top 50 BBC HoldingsRankCompanyCurrent PriceWeightShares Held1SLNOSoleno Therapeutics$75.23+0.3%1.78%2,4292SMMTSummit Therapeutics$27.90+13.1%1.69%6,3003ANABAnaptysBio$21.19-2.4%1.65%7,4904AKROAkero Therapeutics$44.87-1.0%1.56%3,8775LQDALiquidia$15.83+13.2%1.45%10,2216XERSXeris Biopharma$4.71+5.1%1.42%33,0867PTGXProtagonist Therapeutics$45.51+1.2%1.36%2,7868ARQTArcutis Biotherapeutics$15.24+4.0%1.32%9,1879MLYSMineralys Therapeutics$15.42+3.1%1.30%9,24910Bny Mellon Cash Reserve UsdN/A1.25%117,294 Get the Latest News and Ratings for BBC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virtus LifeSci Biotech Clinical Trials ETF and its competitors with MarketBeat's FREE daily newsletter. 11MRUSMerus$44.19-2.8%1.25%2,71912CVACCureVac$3.56+4.7%1.20%35,15113ZYMEZymeworks$12.96+0.6%1.12%8,91714SVRASavara$3.40+4.3%1.09%33,58015ABUSArbutus Biopharma$3.59-0.6%1.08%31,59516SNDXSyndax Pharmaceuticals$13.73-0.7%1.06%8,35617QUREuniQure$14.77-1.5%1.06%7,47518XENEXenon Pharmaceuticals$38.28+0.5%1.05%2,85219DNTHDianthus Therapeutics$21.701.04%4,78820BLTEBelite Bio$62.66+1.2%1.03%1,77521RNAAvidity Biosciences$32.20-1.5%1.01%3,33122ABCLAbCellera Biologics$2.41-3.2%1.00%38,13223CAPRCapricor Therapeutics$11.86-6.9%1.00%7,84724ITOSiTeos Therapeutics$7.77+3.6%1.00%14,15825CELCCelcuity$10.90+0.9%0.99%8,92626RVMDRevolution Medicines$40.72+0.2%0.98%2,50327MNMDMind Medicine (MindMed)$6.93+5.2%0.97%16,02328NUVLNuvalent$77.46+1.6%0.97%1,29629ETNB89bio$8.73+7.4%0.96%14,32830OMEROmeros$7.17+2.1%0.95%13,25531LENZLENZ Therapeutics$29.52+2.2%0.94%3,65532KROSKeros Therapeutics$14.65+0.5%0.93%6,10633RXRXRecursion Pharmaceuticals$5.70+3.6%0.93%16,11434SANASana Biotechnology$1.89-0.5%0.93%55,14235CMPSCOMPASS Pathways$4.19+2.2%0.92%25,51436RGNXREGENXBIO$10.40+5.8%0.92%12,90737VERVVerve Therapeutics$5.19-5.6%0.92%18,05638AVBPArriVent BioPharma$21.30+1.0%0.91%4,34939CYTKCytokinetics$37.35-13.0%0.91%2,24240PHVSPharvaris$18.37+2.9%0.91%5,919Virtually Limitless Energy? (Ad)A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts. This obscure company could be at the center of the next trillion-dollar energy revolution.One company’s discovery could change power forever41NUVBNuvation Bio$2.46+8.4%0.90%42,77542VIRVir Biotechnology$6.16+1.3%0.90%15,13943APGEApogee Therapeutics$40.12+2.3%0.89%2,53744EYPTEyePoint Pharmaceuticals$7.30+2.4%0.89%14,16545MLTXMoonLake Immunotherapeutics$42.32+2.1%0.89%2,09146TRMLTourmaline Bio$16.30-8.7%0.89%4,99847ACLXArcellx$65.55+0.0%0.88%1,34848VRDNViridian Therapeutics$13.62-0.9%0.88%6,25849GPCRStructure Therapeutics$27.09-0.9%0.87%3,54850CNTACentessa Pharmaceuticals$13.61+0.8%0.86%6,673 Geographic ExposureUnited States87.8%Canada2.9%Netherlands2.7%Cayman Islands0.8%Ireland0.6%Singapore0.6%Virgin Islands, British0.6%Currency ExposureUSD100.0%Sector ExposureHealth Care95.7%Energy1.2%Consumer Discretionary0.7%Industry ExposureBiotechnology83.8%Pharmaceuticals11.0%Diversified Consumer Services1.6%Renewable Energy1.2%SubIndustry ExposureBiotechnology79.8%Pharmaceuticals12.5%Renewable Energy Equipment1.2%Coupon Exposure0-20.7% Related Companies and Tools Related Companies PILL Portfolio JDOC Portfolio FTXH Portfolio MEDI Portfolio MEDX Portfolio BIS Portfolio LGHT Portfolio HYLG Portfolio RXD Portfolio GDOC Portfolio This page (NYSEARCA:BBC) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Clinical Trials ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Clinical Trials ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BBC Stock Free BBC Stock Alerts